MBX – mbx biosciences, inc. (US:NASDAQ)
Stock Stats
News
MBX Biosciences to Participate in Upcoming November Investor Conferences
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $44.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $35.00 price target on the stock.
MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock.
Form SC 13D MBX Biosciences, Inc. Filed by: Norwest Venture Partners XVI, LP
Form SC 13D MBX Biosciences, Inc. Filed by: New Enterprise Associates 17, L.P.
Form SC 13D MBX Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
Form SC 13G MBX Biosciences, Inc. Filed by: Deep Track Capital, LP
Form SC 13D MBX Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.